---
title: "Trilogy Mets (TMQ.US) — Financial Reports"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/TMQ.US/norm.md"
symbol: "TMQ.US"
name: "Trilogy Mets"
parent: "https://longbridge.com/en/quote/TMQ.US.md"
datetime: "2026-05-20T17:21:57.646Z"
locales:
  - [en](https://longbridge.com/en/quote/TMQ.US/norm.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/TMQ.US/norm.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/TMQ.US/norm.md)
---

# Trilogy Mets (TMQ.US) — Financial Reports

## Income Statement (USD)

| Indicator | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| EPS | -0.0411 | -0.2066 | -0.0106 | -0.0133 | -0.0222 |
| ROE | -23.01% | -109.80% | -5.40% | -6.66% | -10.96% |
| Revenue | - | - | - | - | - |
| Net income | -7.06M | -34.69M | -1.75M | -2.18M | -3.62M |
| Operating income | -4.62M | -3.28M | -1.13M | -1.65M | -3.23M |
| Gross margin | - | - | - | - | - |
| Net margin | - | - | - | - | - |
| Profit quality | - | - | - | - | - |

## Balance Sheet (USD)

| Indicator | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| A&L | 154.54M | 157.30M | 129.12M | 130.98M | 132.39M |
| Leverage | 1.27 | 1.27 | 1.00 | 1.01 | 1.01 |
| BVPS | 0.7041 | 0.7256 | 0.7832 | 0.7916 | 0.8023 |
| Turnover | - | - | - | - | - |
| Cash & STI | 47.90M | 51.81M | 23.72M | 24.68M | 25.31M |
| Inv & Rec | - | - | - | - | - |
| LT assets | 106000.00 | 117000.00 | 126000.00 | 136000.00 | 145000.00 |
| Net debt | -47.80M | -51.70M | -23.59M | -24.54M | -25.18M |

## Cash Flow Statement (USD)

| Indicator | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| Operating CF | -2.74M | -558000.00 | -1.26M | -677000.00 | -748000.00 |
| Investing CF | -2.50M | -1.00M | - | - | - |
| Financing CF | 1.33M | 29.79M | 22000.00 | 71000.00 | 131000.00 |
| Free CF | 100625.00 | 30.95M | -828125.00 | -495000.00 | 120125.00 |
| OCF coverage | - | - | - | - | - |
| Repaid & issued | - | - | - | - | - |
| CapEx | - | - | - | - | - |